tirzepatide wegovy or ozempic So, here's a quick breakdown: Semaglutide (Wegovy/Ozempic) is a GLP-1 receptor agonist — it mimics a gut hormone that regulates appetite and blood sugar. (Zepbound/Mounjaro) is a dual GIP/GLP-1 agonist — The Future Of Weight-Loss Drugs

Semaglutide itself does not require dose adjustment for renal or hepatic impairment, but your overall medication safety profile depends on how your body processes all compounds together

Although the study focused on autoimmune patients with diabetes, the findings highlight the potential of GLP-1 receptor agonists in managing cardiovascular risk in the broader autoimmune population

The PlexusDx test analyzes variants in GLP1R, GIPR, FTO, and MC4R genes across 14 metabolic pathways, revealing your genetic predisposition to GLP-1 response

Any use outside of authorised clinical trials would be unlicensed and is not recommended